VOGLOYD 3D 1.3MG (Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg))

VOGLOYD 3D 1.3MG TAB is a combination medication primarily used for managing blood sugar levels in patients with type 2 diabetes. It supports patients by helping to improve their body’s response to insulin and managing glucose production in the liver. This can lead to better control over blood sugar levels, which is essential for overall health in those living with diabetes.

The active ingredients in VOGLOYD include Glimepiride, Metformin, and Voglibose. Glimepiride works by stimulating the pancreas to produce more insulin, which helps lower blood sugar levels. Metformin plays a role in reducing glucose absorption in the intestines and improving insulin sensitivity. Voglibose slows down the digestion of carbohydrates, further aiding in the management of blood glucose levels.

For effective results, it is important to take VOGLOYD consistently as directed by a healthcare professional. Store the tablets in a cool, dry place away from direct sunlight to maintain their efficacy. Always follow your healthcare provider’s recommendations regarding diet and exercise, as these can also impact blood sugar management.

Some common, mild side effects may include stomach upset, gas, or a feeling of fullness. It is important to monitor any unusual symptoms and discuss them with your healthcare provider.

This is general information, not a substitute for medical advice. Always consult a doctor/pharmacist and read the package leaflet.